Yat Hang To

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Benjamin N. J. Thomson · 3 shared papers, 2022–2024 · strength 0.47
   • Paper Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data. DOI 10.1038/s41416-024-02619-5↗
   • Paper Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospit… DOI 10.1111/ajco.13721↗
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
2. Peter Gibbs · 3 shared papers, 2022–2024 · strength 0.47
   • Paper Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data. DOI 10.1038/s41416-024-02619-5↗
   • Paper Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospit… DOI 10.1111/ajco.13721↗
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
3. Belinda Lee · 3 shared papers, 2022–2024 · strength 0.47
   • Paper Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data. DOI 10.1038/s41416-024-02619-5↗
   • Paper Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospit… DOI 10.1111/ajco.13721↗
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
4. Shehara Ramyalini Mendis · 2 shared papers, 2022–2024 · strength 0.32
   • Paper Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data. DOI 10.1038/s41416-024-02619-5↗
   • Paper Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospit… DOI 10.1111/ajco.13721↗
5. Benjamin P. T. Loveday · 2 shared papers, 2024 · strength 0.32
   • Paper Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data. DOI 10.1038/s41416-024-02619-5↗
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
6. Adrian M. Fox · 2 shared papers, 2024 · strength 0.32
   • Paper Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data. DOI 10.1038/s41416-024-02619-5↗
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
7. Mehrdad Nikfarjam · 2 shared papers, 2024 · strength 0.32
   • Paper Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data. DOI 10.1038/s41416-024-02619-5↗
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
8. Adnan M. Nagrial · 2 shared papers, 2022–2024 · strength 0.31
   • Paper Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospit… DOI 10.1111/ajco.13721↗
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
9. Sam Banks · 1 shared paper, 2024 · strength 0.15
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
10. Hyun Soo Ko · 1 shared paper, 2024 · strength 0.15
    • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
11. Matthew Burge · 1 shared paper, 2024 · strength 0.15
    • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.